More from the series Subscribe: Apple Podcasts Spotify Injectable peptide therapy, a controversial wellness trend that caught fire online in 2025, shows no signs of slowing down in 2026, despite an overwhelming lack of safety data
While food cannot replicate the potency or duration of GLP-1 medications, research suggests that the foods we choose at each meal can stimulate different amounts of GLP-1 release
Alkaloids used as medicines: structural phytochemistry meets biodiversity-an update and forward look
Other symptoms include Depression and anxiety Baldness (in men) Reduction in sexual desire and activity Reduced strength and muscular mass Concentration issues and memory issues Thin, dry skin Increased triglycerides and lipids Tiredness or drowsiness Cardiovascular problems, including hypertension High LDL (the bad) cholesterol levels Insulin resistance and blood glucose level fluctuation Reduced capacity for exercise Decreased bone mineral density Sensitive to cold and heat Gaining body mass, particularly around the waist Without treatment, growth hormone deficiency can significantly impact the quality of life
They mimic the GLP-1 (glucagon-like peptide 1) hormone produced in the gut as a response to eating, which raises insulin production and lowers blood sugar
